Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1994 1
1996 2
1997 2
2014 1
2015 4
2016 7
2017 3
2018 3
2020 5
2021 7
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Results by year

Filters applied: . Clear all
Page 1
Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial.
Scolari F, Delbarba E, Santoro D, Gesualdo L, Pani A, Dallera N, Mani LY, Santostefano M, Feriozzi S, Quaglia M, Boscutti G, Ferrantelli A, Marcantoni C, Passerini P, Magistroni R, Alberici F, Ghiggeri GM, Ponticelli C, Ravani P; RI-CYCLO Investigators. Scolari F, et al. J Am Soc Nephrol. 2021 Apr;32(4):972-982. doi: 10.1681/ASN.2020071091. Epub 2021 Mar 1. J Am Soc Nephrol. 2021. PMID: 33649098 Free PMC article.
Diagnosis of complement alternative pathway disorders.
Angioi A, Fervenza FC, Sethi S, Zhang Y, Smith RJ, Murray D, Van Praet J, Pani A, De Vriese AS. Angioi A, et al. Kidney Int. 2016 Feb;89(2):278-88. doi: 10.1016/j.kint.2015.12.003. Kidney Int. 2016. PMID: 26806831 Free article. Review.
[Transplant Candidate with Cancer: Should We Proceed?].
Mascia G, Floris M, Angioi A, Argiolas D, Lepori N, Cabiddu G, Pani A. Mascia G, et al. Among authors: angioi a. G Ital Nefrol. 2023 Oct 3;40(Suppl 81):2023-S81. G Ital Nefrol. 2023. PMID: 38007833 Review. Italian.
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy.
Schena FP, Anelli VW, Trotta J, Di Noia T, Manno C, Tripepi G, D'Arrigo G, Chesnaye NC, Russo ML, Stangou M, Papagianni A, Zoccali C, Tesar V, Coppo R; members of the VALIGA study. Schena FP, et al. Kidney Int. 2021 May;99(5):1179-1188. doi: 10.1016/j.kint.2020.07.046. Epub 2020 Sep 2. Kidney Int. 2021. PMID: 32889014
Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy.
Feehally J, Coppo R, Troyanov S, Bellur SS, Cattran D, Cook T, Roberts IS, Verhave JC, Camilla R, Vergano L, Egido J, Wiecek A, Karkoszka H, Tesar V, Maixnerova D, Ots-Rosenberg M, Quaglia M, Rollino C, Magistroni R, Cusinato S, Cravero R, Peruzzi L, Lundberg S, Gesualdo L, Cancarini G, Feriozzi S, Ferrario F; VALIGA study of ERA-EDTA Immunonephrology Working Group. Feehally J, et al. Nephron. 2016;132(1):15-24. doi: 10.1159/000441852. Epub 2015 Nov 20. Nephron. 2016. PMID: 26586175
38 results